What Happened to the COVID-19 Vaccine Patent Waiver?
The negotiations leading to the WTO Decision proved once again the inadequacy of the debate over intellectual property rights.
WTO
-
Read more: What Happened to the COVID-19 Vaccine Patent Waiver? -
Read more: Accessing COVID-19 mRNA Vaccines for Research: The Re-emergence of the Tragedy of the ‘Anticommons’ Accessing COVID-19 mRNA Vaccines for Research: The Re-emergence of the Tragedy of the ‘Anticommons’
COVID-19 vaccine manufacturers refusing to share samples may be the latest example of the tragedy of the “anticommons” in biomedical research.
-
Read more: The Proposed TRIPS Compromise Risks Setting Several Bad Precedents The Proposed TRIPS Compromise Risks Setting Several Bad Precedents
The proposal introduces precedents that will be used to justify further narrowing of TRIPS flexibilities.
